Experimental data supports that roxadustat may increase infection by upregulating HIF-1α and affecting adaptive immune responses [34], but we did not get the result that roxadustat will increase the infection, either upper respiratory or urinary tract infection. Here, HIF1A is linked to urinary tract infection.